Two new reports just dropped into the national debate and they deserve a cold, clear-eyed look. The White House Council of Economic Advisers put a giant $47.4 trillion price tag on a generous “single‑payer, first‑dollar” Medicare for All plan, and the Fraser Institute’s annual study says Canadians now wait a median 30.7 weeks from doctor referral to specialist treatment. Those aren’t trivia facts — they are the hard numbers Democrats will need to explain if they plan to sell a one-size-fits-all government plan as “free” and instant.
The $47 Trillion Headline: What it Actually Means
The CEA number is brutal — but it measures something specific: the projected change in federal deficits under a very broad single‑payer model where the government pays nearly all health bills. That explains why critics seized the figure and why Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz and others are quoting it. Yes, other studies, like a Yale modeling preprint, say total national health spending could fall under certain designs. But “national spending” vs. “federal deficit” are not the same thing. Democrats who promise savings and no new taxes owe voters a plain answer about who writes the checks and how much it will raise in federal spending.
Seven‑Month Waits: The Canada Comparison
The Fraser Institute finds a median 30.7‑week wait from family‑doctor referral to treatment in Canada. That’s the real-world experience of a single‑payer system — long waits for many procedures are a predictable outcome when access expands without matching increases in provider capacity or payment incentives. The U.S. has far more hospital capacity and higher pay for providers today, but that could change fast if Washington slashes reimbursement to “find savings.” Rural hospitals, already fragile, would likely be the first to feel the squeeze. Voters should ask whether they want American care that looks more like Canada’s calendar than America’s clinic schedule.
Competing Claims and the “Magic Asterisk” Problem
Supporters point to the Yale preprint that projects about $1.04 trillion in annual savings and tens of thousands of lives saved. It’s worth noting that study is not peer‑reviewed yet and rests on optimistic assumptions about drug pricing, fraud reduction, and efficiency gains — the “magic asterisk” critics keep mentioning. Other respected analysts produce wildly different totals depending on payment rates, benefit design, and whether private spending gets shifted to the federal balance sheet. In short: you can pick numbers that prove whatever story you want — but picking a number doesn’t replace honest policy design.
Here’s the plain Republican answer: if Democrats want to nationalize U.S. health care, they must stop pretending it’s costless or that queues won’t get worse. We can and should fix real problems — surprise bills, preexisting-condition coverage gaps, high drug prices — without torching choice, bankrupting hospitals, or handing Washington control of every doctor’s schedule. The debate should be honest about tradeoffs. Voters deserve that much, and conservatives should keep making the fiscally common‑sense case every chance we get.

